{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T01:23:29Z","timestamp":1782177809734,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005866","name":"Far Eastern Memorial Hospital","doi-asserted-by":"publisher","award":["FEMH-2013- D-015"],"award-info":[{"award-number":["FEMH-2013- D-015"]}],"id":[{"id":"10.13039\/501100005866","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jfma.2023.12.007","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T18:30:09Z","timestamp":1702405809000},"page":"710-715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effect of tibolone versus hormone replacement therapy on lower urinary tract symptoms and sexual function"],"prefix":"10.1016","volume":"123","author":[{"given":"Sheng-Mou","family":"Hsiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiow-Ru","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2023.12.007_bib1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.maturitas.2015.12.004","article-title":"The effects of pre-operative menopausal status and hormone replacement therapy (HRT) on sexuality and quality of life after risk-reducing salpingo-oophorectomy","volume":"85","author":"Tucker","year":"2016","journal-title":"Maturitas"},{"key":"10.1016\/j.jfma.2023.12.007_bib2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.7748\/ns2013.11.28.12.48.e8067","article-title":"Managing menopausal symptoms: hot flushes and night sweats","volume":"28","author":"Brockie","year":"2013","journal-title":"Nurs Stand"},{"key":"10.1016\/j.jfma.2023.12.007_bib3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1743-6109.2007.00726.x","article-title":"Tibolone and transdermal E2\/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial","volume":"5","author":"Nijland","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.jfma.2023.12.007_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.maturitas.2005.02.011","article-title":"Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group","volume":"51","author":"Kenemans","year":"2005","journal-title":"Maturitas"},{"issue":"Suppl 1","key":"10.1016\/j.jfma.2023.12.007_bib5","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jfma.2023.01.013","article-title":"Asia-pacific consensus on osteoporotic fracture prevention in postmenopausal women with low bone mass or osteoporosis but no fragility fractures","volume":"122","author":"Huang","year":"2023","journal-title":"J Formos Med Assoc"},{"issue":"4 Suppl 1","key":"10.1016\/j.jfma.2023.12.007_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0090-4295(03)00676-9","article-title":"The role of estrogens in female lower urinary tract dysfunction","volume":"62","author":"Robinson","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.jfma.2023.12.007_bib7","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/01.gme.0000247016.41007.c9","article-title":"Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study","volume":"13","author":"Swanson","year":"2006","journal-title":"Menopause"},{"key":"10.1016\/j.jfma.2023.12.007_bib8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.maturitas.2012.11.001","article-title":"Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study","volume":"74","author":"Polisseni","year":"2013","journal-title":"Maturitas"},{"key":"10.1016\/j.jfma.2023.12.007_bib9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/09513590400027240","article-title":"Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate","volume":"20","author":"Uygur","year":"2005","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jfma.2023.12.007_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0378-5122(00)00134-1","article-title":"The comparison of effects of tibolone and conjugated estrogen-medroxyprogesterone acetate therapy on sexual performance in postmenopausal women","volume":"36","author":"K\u00f6k\u00e7\u00fc","year":"2000","journal-title":"Maturitas"},{"key":"10.1016\/j.jfma.2023.12.007_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0378-5122(95)00953-1","article-title":"Tibolone versus conjugated estrogens and sequential progestogen in the treatment of climacteric complaints","volume":"23","author":"Egarter","year":"1996","journal-title":"Maturitas"},{"key":"10.1016\/j.jfma.2023.12.007_bib12","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/cmt.4.4.314.319","article-title":"Quality of life and sexuality changes in postmenopausal women receiving tibolone therapy","volume":"4","author":"Wu","year":"2001","journal-title":"Climacteric"},{"key":"10.1016\/j.jfma.2023.12.007_bib13","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0022-5347(17)36966-5","article-title":"The American urological association symptom index for benign prostatic hyperplasia, the measurement committee of the American urological association","volume":"148","author":"Barry","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.jfma.2023.12.007_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00192-012-1818-8","article-title":"International Prostate Symptom Score for assessing lower urinary tract dysfunction in women","volume":"24","author":"Hsiao","year":"2013","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.jfma.2023.12.007_bib15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2000","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/j.jfma.2023.12.007_bib16","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1743-6109.2009.01247.x","article-title":"Developing and validating a Taiwan version of the female sexual function index for pregnant women","volume":"6","author":"Chang","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.jfma.2023.12.007_bib17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00192-016-3129-y","article-title":"Effects of laser procedure for female urodynamic stress incontinence on pad weight, urodynamics, and sexual function","volume":"28","author":"Tien","year":"2017","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.jfma.2023.12.007_bib18","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.tjog.2018.10.015","article-title":"Impact of the mid-urethral sling for stress urinary incontinence on female sexual function and their partners' sexual activity","volume":"57","author":"Hsiao","year":"2018","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.jfma.2023.12.007_bib19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/1536867X0900900208","article-title":"The Skillings-Mack test (Friedman test when there are missing data)","volume":"9","author":"Chatfield","year":"2009","journal-title":"STATA J"},{"key":"10.1016\/j.jfma.2023.12.007_bib20","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/GME.0000000000001749","article-title":"Nocturia and hormone therapy: impact on sleep?","volume":"28","author":"Takacs","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.jfma.2023.12.007_bib21","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/GME.0000000000001741","article-title":"Hormone therapy as a possible solution for postmenopausal women with nocturia: results of a pilot trial","volume":"28","author":"Pauwaert","year":"2021","journal-title":"Menopause"},{"key":"10.1016\/j.jfma.2023.12.007_bib22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jfma.2021.04.005","article-title":"Impacts of nocturia on quality of life, mental health, work limitation, and health care seeking in China, Taiwan and South Korea (LUTS Asia): results from a cross-sectional, population-based study","volume":"121","author":"Chow","year":"2022","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2023.12.007_bib23","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.jfma.2020.08.016","article-title":"Prevalence of detrusor underactivity and bladder outlet obstruction in women with cystocele and changes in voiding function after cystocele repair","volume":"119","author":"Chang","year":"2020","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2023.12.007_bib24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jfma.2018.03.006","article-title":"The prevalence and bother of lower urinary tract symptoms in men and women aged 40 years or over in Taiwan","volume":"118","author":"Liu","year":"2019","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2023.12.007_bib25","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1016\/j.jfma.2022.07.011","article-title":"Clinical outcome and urodynamic changes of tailored transvaginal mesh surgery for pelvic organ prolapse: a mid-term 40 Months follow-up","volume":"121","author":"Wu","year":"2022","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2023.12.007_bib26","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1743-6109.2007.00635.x","article-title":"Comparison of the effects of hormone therapy regimens, oral and vaginal estradiol, estradiol + drospirenone and tibolone, on sexual function in healthy postmenopausal women","volume":"5","author":"Cayan","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.jfma.2023.12.007_bib27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/13697130903009195","article-title":"Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women","volume":"13","author":"Ziaei","year":"2010","journal-title":"Climacteric"},{"key":"10.1016\/j.jfma.2023.12.007_bib28","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.maturitas.2006.04.014","article-title":"Clitoral circulation in postmenopausal women with sexual dysfunction: a pilot randomized study with hormone therapy","volume":"55","author":"Nappi","year":"2006","journal-title":"Maturitas"},{"key":"10.1016\/j.jfma.2023.12.007_bib29","first-page":"CD008536","article-title":"Short-term and long-term effects of tibolone in postmenopausal women","volume":"10","author":"Formoso","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jfma.2023.12.007_bib30","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.3390\/jcm12103388","article-title":"Understanding progestins: from basics to clinical applicability","volume":"12","author":"Garc\u00eda-S\u00e1enz","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jfma.2023.12.007_bib31","first-page":"CD009672","article-title":"Hormone therapy for sexual function in perimenopausal and postmenopausal women","volume":"6","author":"Nastri","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jfma.2023.12.007_bib32","article-title":"Conjugated equine estrogen used in postmenopausal women associated with a higher risk of stroke than estradiol","volume":"11","author":"Chang","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jfma.2023.12.007_bib33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0378-5122(96)01069-9","article-title":"Effect on sexual life--a comparison between tibolone and a continuous estradiol-norethisterone acetate regimen","volume":"26","author":"Nathorst-B\u00f6\u00f6s","year":"1997","journal-title":"Maturitas"},{"key":"10.1016\/j.jfma.2023.12.007_bib34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2023.12.007_bib35","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","article-title":"Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial","volume":"289","author":"Chlebowski","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2023.12.007_bib36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/jwh.2019.7828","article-title":"Trends in prescribing menopausal hormone therapy and bisphosphonates in Australia and Manitoba, Canada and adherence to recommendations","volume":"29","author":"Salagame","year":"2020","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.jfma.2023.12.007_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/pds.1273","article-title":"Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication","volume":"16","author":"Guay","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jfma.2023.12.007_bib38","first-page":"726","article-title":"Initial 17beta-estradiol dose for treating vasomotor symptoms","volume":"95","author":"Notelovitz","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jfma.2023.12.007_bib39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00042192-200007050-00005","article-title":"Suppression of vasomotor and vulvovaginal symptoms with continuous oral 17 beta-estradiol","volume":"7","author":"Notelovitz","year":"2000","journal-title":"Menopause"},{"key":"10.1016\/j.jfma.2023.12.007_bib40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/13697139809085544","article-title":"Do combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms?","volume":"1","author":"Baerug","year":"1998","journal-title":"Climacteric"},{"issue":"Suppl 12B","key":"10.1016\/j.jfma.2023.12.007_bib41","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.amjmed.2005.09.035","article-title":"Vasomotor symptom relief versus unwanted effects: role of estrogen dosage","volume":"118","author":"Ettinger","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.jfma.2023.12.007_bib42","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archinte.168.8.861","article-title":"Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy","volume":"168","author":"Grodstein","year":"2008","journal-title":"Arch Intern Med"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664623004874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664623004874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T18:05:10Z","timestamp":1720721110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664623004874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0929664623004874"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2023.12.007","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of tibolone versus hormone replacement therapy on lower urinary tract symptoms and sexual function","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2023.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}